In this episode, we explore brexanolone and zuranolone—the first FDA-approved medications specifically for postpartum depression. How do these neurosteroid-based treatments work differently than traditional antidepressants, and could they offer relief in just days rather than weeks?

Faculty: Lauren Osborne, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Understanding Postpartum Mood Disorders: A Comprehensive Guide
• The Role of Brexanolone and Zuranolone in Postpartum Depression